Lung cancer (Amsterdam, Netherlands)HumansAntineoplastic Combined Chemotherapy ProtocolsDrug ResistanceNeoplasmImmunotherapy
Systematic review and network meta-analysis: evaluation of systemic therapies for platinum refractory or resistant small cell lung cancer.
Rahul K Desai, Elena J Zhou, Kelvin K W Chan
Published: 202510.1016/j.lungcan.2025.108812
Abstract
BACKGROUND: Platinum-refractory/resistant (r/r) small cell lung cancer (SCLC) is associated with poor prognosis and limited treatment options. While chemotherapy has been the standard, recent randomized controlled trials (RCTs) have investigated immu…
Preview only. Read the full abstract at the source